We are live on ! Find out more
CSLT

CASTLIGHT HEALTH, INC.

Delisted

CSLT was delisted on the 16th of February, 2022.

105 hedge funds and large institutions have $155M invested in CASTLIGHT HEALTH, INC. in 2018 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 34 increasing their positions, 32 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 15

6% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 32

1% more funds holding

Funds holding: 104105 (+1)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

16% less capital invested

Capital invested by funds: $184M → $155M (-$28.5M)

29% less call options, than puts

Call options by funds: $34K | Put options by funds: $48K

Holders
105
Holders Change
+1
Holders Change %
+0.96%
% of All Funds
2.34%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
16
Increased
34
Reduced
32
Closed
15
Calls
$34K
Puts
$48K
Net Calls
-$14K
Net Calls Change
-$34K
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$33.1M +$5.88M +2,371,475 +18%
BlackRock
2
BlackRock
New York
$14.4M +$2.08M +839,880 +15%
WT
3
Wellcome Trust
United Kingdom
$14.3M
OMC
4
Oak Management Corp
Connecticut
$12.9M
Vanguard Group
5
Vanguard Group
Pennsylvania
$11.7M -$2.15M -865,251 -14%
Wellington Management Group
6
Wellington Management Group
Massachusetts
$6.41M -$200K -80,632 -3%
CAM
7
Cortina Asset Management
Wisconsin
$5.28M +$1.44M +581,132 +31%
CPA
8
Cowen Prime Advisors
New York
$4.76M +$60.2K +24,250 +1%
GS
9
Gagnon Securities
New York
$4.29M -$1.56M -629,626 -24%
MC
10
Maverick Capital
Texas
$3.84M
State Street
11
State Street
Massachusetts
$2.89M -$71.2K -28,719 -2%
GA
12
Gagnon Advisors
New York
$2.54M -$535K -215,544 -16%
RA
13
Royce & Associates
New York
$2.44M +$105K +42,240 +4%
Dimensional Fund Advisors
14
Dimensional Fund Advisors
Texas
$2.39M +$775K +312,240 +40%
BG
15
Bellevue Group
Switzerland
$2.3M +$423K +170,673 +19%
Northern Trust
16
Northern Trust
Illinois
$2.04M -$76.8K -30,966 -3%
PCMI
17
Paradigm Capital Management Inc
New York
$2.02M -$197K -79,600 -8%
Renaissance Technologies
18
Renaissance Technologies
New York
$1.94M +$544K +219,400 +33%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$1.79M +$213K +85,867 +12%
RCM
20
Raging Capital Management
New Jersey
$1.56M +$1.78M +717,709 New
Carson Wealth (CWM LLC)
21
Carson Wealth (CWM LLC)
Nebraska
$1.37M +$151K +60,922 +11%
D.E. Shaw & Co
22
D.E. Shaw & Co
New York
$1.33M +$330K +132,944 +28%
AQR Capital Management
23
AQR Capital Management
Connecticut
$1.23M +$456K +183,750 +48%
RHJA
24
Rice Hall James & Associates
California
$1.22M +$665K +268,098 +92%
T. Rowe Price Associates
25
T. Rowe Price Associates
Maryland
$1.08M +$419 +169 +0%

CSLT Hedge Fund Activity: Q4 2018 in Review

105 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in CASTLIGHT HEALTH, INC. (CSLT) for Q4 2018, worth a combined $155M — down 16% from $184M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new CSLT positions and 15 closed out — a net gain of 1 holder — while 34 added to existing stakes and 32 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $5.88M. The largest seller was Vanguard Group, cutting an estimated $2.15M.

  • 105 institutional investors held CASTLIGHT HEALTH, INC. (CSLT) as of Q4 2018, up from 104 in Q3 2018.
  • Funds reported $155M of CASTLIGHT HEALTH, INC. stock for Q4 2018, down 16% quarter-over-quarter.
  • 16 funds opened new CASTLIGHT HEALTH, INC. positions in Q4 2018 and 15 closed out, a net change of +1 holder.
  • The largest CASTLIGHT HEALTH, INC. buyer in Q4 2018 was Fidelity Investments, an estimated $5.88M added.
  • The largest CASTLIGHT HEALTH, INC. seller in Q4 2018 was Vanguard Group, an estimated $2.15M sold.

Based on aggregated 13F filings for Q4 2018.